Physician profile
Matthew D Moore
NPI 1700076635
$6,729.13
in general payments reported to CMS, 2019-2025
41 companies · $668 in 2025
The $668 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,970 · 2020: $211 · 2021: $939 · 2022: $239 · 2023: $605 · 2024: $1,098 · 2025: $668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,979 · Debt Forgiveness: $392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,979.26 |
| Debt Forgiveness | $391.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $3,201.24 | 2019-2025 | |
| Olympus America INC. | $752.23 | 2021-2025 | Olympus, 4k Camera Head, Gastrointestinal Videoscope |
| Abbvie INC. | $398.49 | 2019-2023 | |
| Organon LLC | $314.40 | 2022-2025 | Nexplanon |
| Coopersurgical, INC. | $242.69 | 2019-2024 | Paragard T 380a, Supercut Hysterectomy Scissors, Paragard T 380a |
| Hologic Sales and Service, LLC | $219.32 | 2020-2025 | Aptima, Acessa Provu System |
| Gynesonics, INC. | $142.08 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Leica Microsystems INC. | $113.51 | 2021 | |
| Angiodynamics, INC. | $107.87 | 2020-2023 | Smart Port Ct |
| Alexion Pharmaceuticals, INC. | $106.32 | 2019 | |
| Viiv Healthcare Company | $105.44 | 2023 | Apretude |
| Ethicon US, LLC | $96.56 | 2019-2025 | Dermabond Prineo, Stratafix, Enseal X1 |
| Pfizer INC. | $95.45 | 2023-2025 | |
| Intuitive Surgical, INC. | $93.33 | 2025 | |
| Stryker Corporation | $62.20 | 2024 | 1788 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Channel Medsystems, INC. | $54.34 | 2023 | |
| Myovant Sciences INC. | $49.99 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $43.95 | 2023-2025 | Myfembree |
| Boston Scientific Corporation | $42.97 | 2019-2024 | Solyx Sis System |
| Astellas Pharma US INC | $36.57 | 2023-2024 | Veozah |
| Evofem Biosciences, INC. | $36.43 | 2021-2023 | Phexxi |
| Bausch & Lomb Americas INC. | $36.11 | 2024 | Envista Mx60 Iol, Stellaris |
| Merck Sharp & Dohme LLC | $32.93 | 2019 | |
| Mayne Pharma Commercial LLC | $32.17 | 2021 | |
| Glaukos Corporation | $31.36 | 2024 | Idose |
| Biogen, INC. | $25.03 | 2024 | |
| Dexcom, INC. | $24.73 | 2023 | Dexcom G6 Transmitter |
| Avion Pharmaceuticals | $21.92 | 2021 | |
| Aspira Women'S Health INC | $21.72 | 2024 | Ova1 |
| Mylan Pharmaceuticals INC. | $20.83 | 2022 | |
| Monaghan Medical Corporation | $20.23 | 2022 | |
| Northgate Technologies, INC. | $20.23 | 2022 | |
| Agile Therapeutics, INC. | $19.37 | 2021 | |
| Optumhealth Care Solutions, LLC | $17.00 | 2023 | Vivify Health Care Team Portal |
| Kci USA, INC. | $15.63 | 2020 | |
| Medtronic, INC. | $15.46 | 2022 | |
| Lensar, INC. | $14.86 | 2024 | Lensar Laser System |
| Exeltis, USA INC. | $14.70 | 2021 | |
| Innovation Technologies INC | $13.36 | 2024 | Irrisept |
| Lupin INC. | $11.52 | 2019 | |
| Meditrina | $4.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.